This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Relinia, Inc., Other. Active years: 1996-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- La Place, LA (US) (1996)
- Euless, TX (US) (2022)
Company Filing History:
2 out of 2 
1 out of 834,513 Years Active: 1996-2025
Title: David C Foster: Innovator in Therapeutic Proteins
Introduction
David C Foster is a notable inventor based in Euless, Texas, with a focus on developing innovative therapeutic proteins. He holds three patents that contribute significantly to the field of medicine, particularly in the area of immune modulation.
Latest Patents
Foster's latest patents include the invention of single-chain TNF receptor 2 agonist fusion proteins. This invention provides for a fusion protein between a single chain TNFR2 Selective Agonist protein and a dimerization domain, such as an IgGFc protein. The single chain TNFR2 Selective Agonist moiety offers therapeutic activity by selectively activating the TNFR2 form of the TNF-α receptor, thus selectively stimulating Tregs and/or increasing myelin deposition.
Career Highlights
Throughout his career, David C Foster has worked with various companies, including Relinia, Inc. His contributions to the field have been recognized through his innovative patents and research.
Collaborations
Foster has collaborated with notable professionals in his field, including Lutz B Giebel and Leonard G Presta. Their combined expertise has likely enhanced the development of his inventions.
Conclusion
David C Foster's work in the development of therapeutic proteins showcases his commitment to advancing medical science. His patents reflect significant innovations that may lead to improved treatments for various conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile